Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Japanese Journal of Radiology
Published in: Japanese Journal of Radiology 9/2016

01-09-2016 | Special Report

Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts

Authors: Masaya Miyazaki, Toshihiro Iguchi, Haruyuki Takaki, Takashi Yamanaka, Yoshitaka Tamura, Hiroyuki Tokue, Yozo Sato, Osamu Ikeda, Tadashi Shimizu, Koichiro Yamakado

Published in: Japanese Journal of Radiology | Issue 9/2016

Login to get access

Abstract

Purpose

A panel of Japanese experts on tumor ablation therapy gathered to reach a general consensus on topics surrounding ablation therapy.

Materials and methods

Questionnaires relating to ablation protocols for radiofrequency ablation (RFA) and cryoablation, as well as ancillary procedures required for safe and secure ablation therapy, were sent to seven institutions. Experts from these institutions discussed each topic based on the evidence and the questionnaire data, and a consensus was reached at an annual meeting of the Japan Image-guided Ablation Group in Maebashi, Japan, in October 2015.

Results

A consensus was reached on each of six topics, including “management of antiplatelet and anticoagulation drug therapy”; “pain control in the perioperative period”; “arterial embolization combined with ablation therapy”; “protection of non-target organs”; “RFA and cryoablation protocols”; and “ablative margins.”

Conclusions

The consensus achieved here will serve as the framework for tumor ablation therapies in Japan.
Literature
1.
Ye X, Fan W, Chen JH, Feng WJ, Gu SZ, Han Y, et al. Chinese expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer. 2015;6(1):112–21.PubMedPubMedCentralCrossRef
2.
Yamanaka T, Yamakado K, Yamada T, Fujimori M, Takaki H, Nakatsuka A, et al. CT-guided percutaneous cryoablation in renal cell carcinoma: factors affecting local tumor control. J Vasc Interv Radiol: JVIR. 2015;26(8):1147–53.PubMedCrossRef
3.
Nakatsuka A, Yamakado K, Uraki J, Takaki H, Yamanaka T, Fujimori M, et al. Safety and clinical outcomes of percutaneous radiofrequency ablation for intermediate and large bone tumors using a multiple-electrode switching system: a phase II clinical study. J Vasc Interv Radiol: JVIR. 2015.
4.
Kumasaka S, Miyazaki M, Tsushima Y. CT-guided percutaneous cryoablation of an aggressive osteoblastoma: a case report. J Vasc Interv Radiol: JVIR. 2015;26(11):1746–8.PubMedCrossRef
5.
Yamakado K, Matsumine A, Nakamura T, Nakatsuka A, Takaki H, Matsubara T, et al. Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. Int J Clin Oncol. 2014;19(5):955–62.PubMedCrossRef
6.
Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, et al. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol. 2013;18(1):46–53.PubMedCrossRef
7.
Iguchi T, Inoue D, Yabushita K, Sakaguchi K, Tatsukawa M, Sasaki H, et al. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung. Br J Radiol. 1016;2012(85):e373–7.
8.
Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol: JVIR. 2012;23(1):48–54.PubMedCrossRef
9.
Miyazaki M, Aoki J, Miyazaki A, Nakajima T, Koyama Y, Shinozaki T, et al. Percutaneous radiofrequency ablation of osteoid osteoma using cool-tip electrodes without the cooling system. Jpn J Radiol. 2011;29(2):138–43.PubMedCrossRef
10.
Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231(3):850–7.PubMedCrossRef
11.
Yamakado K, Nakatsuka A, Akeboshi M, Takeda K. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol: JVIR. 2003;14(9 Pt 1):1183–6.PubMedCrossRef
12.
Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the Interventional Oncology Sans Frontieres meeting 2013. Eur Radiol. 2015;25(12):3438–54.PubMedPubMedCentralCrossRef
13.
Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol: JVIR. 2014;25(11):1691–705, e4.
14.
Takaki H, Yamakado K, Nakatsuka A, Yamada T, Shiraki K, Takei Y, et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013;200(3):658–64.PubMedCrossRef
15.
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.PubMedCrossRef
16.
Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):116–28.PubMedCrossRef
17.
Guidelines for the management of anticoagulant and antiplatelet therapy in patients with cardiovascular diseases. Japanese Circulation Society. 2009.
18.
Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc. 2007;138(5):652–5.PubMedCrossRef
19.
Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62(8):1217–20.PubMedCrossRef
20.
Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e89S–119S.PubMedPubMedCentralCrossRef
21.
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med. 2009;361(12):1139–51.PubMedCrossRef
22.
Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. New Engl J Med. 2015;373(9):823–33.PubMedPubMedCentralCrossRef
23.
de Baere T. Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Interv Radiol. 2011;34(2):241–51.CrossRef
24.
Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71.PubMedPubMedCentralCrossRef
25.
Sofocleous CT, Sideras P, Petre EN. “How we do it”—a practical approach to hepatic metastases ablation techniques. Tech Vasc Interv Radiol. 2013;16(4):219–29.PubMedCrossRef
26.
Yokoyama K, Ikeda O, Kawanaka K, Nakasone Y, Inoue S, Tamura Y, et al. Pain control in patients with hepatocellular carcinoma treated by percutaneous radiofrequency ablation: comparison of the efficacy of one-shot and continuous intravenous fentanyl delivery. Acta Radiol. 2014;55(10):1219–25.PubMedCrossRef
27.
Kang TW, Rhim H, Lee MW, Kim YS, Choi D, Lee WJ, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy. AJR Am J Roentgenol. 2011;196(4):907–13.PubMedCrossRef
28.
Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Nakamura K, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Interv Radiol. 2008;31(1):122–30.CrossRef
29.
Gazzera C, Fonio P, Faletti R, Dotto MC, Gobbi F, Donadio P, et al. Role of paravertebral block anaesthesia during percutaneous transhepatic thermoablation. Radiol Med (Torino). 2014;119(8):549–57.CrossRef
30.
Hiraki T, Gobara H, Shibamoto K, Mimura H, Soda Y, Uka M, et al. Technique for creation of artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors: report of seven cases. J Vasc Interv Radiol: JVIR. 2011;22(4):503–6.PubMedCrossRef
31.
Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation—initial observations. Radiology. 2005;237(1):366–70.PubMedCrossRef
32.
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38.PubMedCrossRef
33.
Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, et al. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014;32(4):242–50.PubMedCrossRef
34.
Yamanaka T, Yamakado K, Takaki H, Nakatsuka A, Shiraki K, Hasegawa H, et al. Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas. Jpn J Radiol. 2012;30(7):553–9.PubMedCrossRef
35.
Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, et al. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol: JVIR. 2005;16(6):849–56.PubMedCrossRef
36.
Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol. 2014;20(29):10174–82.PubMedPubMedCentralCrossRef
37.
Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2013;19(24):3872–82.PubMedPubMedCentralCrossRef
38.
Rhim H, Lee MH, Kim YS, Choi D, Lee WJ, Lim HK. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol. 2008;190(5):1324–30.PubMedCrossRef
39.
Goto E, Tateishi R, Shiina S, Masuzaki R, Enooku K, Sato T, et al. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol. 2010;44(5):374–80.PubMed
40.
Chen JX, Guzzo TJ, Malkowicz SB, Soulen MC, Wein AJ, Clark TW, et al. Complication and readmission rates following same-day discharge after percutaneous renal tumor ablation. J Vasc Interv Radiol: JVIR. 2016;27(1):80–6.PubMedCrossRef
41.
Miller JM, Julien P, Wachsman A, Van Allan RJ, Friedman ML. The role of embolization in reducing the complications of cryoablation in renal cell carcinoma. Clin Radiol. 2014;69(10):1045–9.PubMedCrossRef
42.
Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):72–80.PubMedCrossRef
43.
Campbell C, Lubner MG, Hinshaw JL, Munoz del Rio A, Brace CL. Contrast media-doped hydrodissection during thermal ablation: optimizing contrast media concentration for improved visibility on CT images. AJR. Am J Roentgenol. 2012;199(3):677–82.CrossRef
44.
Hasegawa T, Takaki H, Miyagi H, Nakatsuka A, Uraki J, Yamanaka T, et al. Hyaluronic acid gel injection to prevent thermal injury of adjacent gastrointestinal tract during percutaneous liver radiofrequency ablation. Cardiovasc Interv Radiol. 2013;36(4):1144–6.CrossRef
45.
46.
Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229(1):171–5.PubMedCrossRef
47.
48.
Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–90.PubMedCrossRef
49.
Ni Y, Mulier S, Miao Y, Michel L, Marchal G. A review of the general aspects of radiofrequency ablation. Abdom Imaging. 2005;30(4):381–400.PubMedCrossRef
50.
Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, et al. Determination of the nonlethal margin inside the visible “ice-ball” during percutaneous cryoablation of renal tissue. Cardiovasc Interv Radiol. 2013;36(3):783–90.CrossRef
51.
Metadata
Title
Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts
Authors
Masaya Miyazaki
Toshihiro Iguchi
Haruyuki Takaki
Takashi Yamanaka
Yoshitaka Tamura
Hiroyuki Tokue
Yozo Sato
Osamu Ikeda
Tadashi Shimizu
Koichiro Yamakado
Publication date
01-09-2016
Publisher
Springer Japan
Published in
Japanese Journal of Radiology / Issue 9/2016
Print ISSN: 1867-1071
Electronic ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-016-0569-8

Other articles of this Issue 9/2016

Japanese Journal of Radiology 9/2016 Go to the issue

Original Article

Reduction of misregistration on cerebral four-dimensional computed tomography angiography images using advanced patient motion correction reconstruction

Original Article

Can an enhanced thin-slice computed tomography delineate the right adrenal vein and improve the success rate?

Original Article

Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma

Original Article

Single-energy metal artifact reduction for helical computed tomography of the pelvis in patients with metal hip prostheses

Original Article

Rebound adenoid hyperplasia after chemotherapy in pediatric patients with head and neck lymphoma: MR imaging findings

Original Article

Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery